Sanofi India, Emcure Pharma announce exclusive distribution partnership
Sanofi India and Emcure Pharmaceuticals on Monday announced an exclusive distribution and promotion agreement for Sanofi’s cardiovascular products in India. Effective immediately, Emcure Pharmaceuticals will exclusively distribute and promote Sanofi India’s Cardiovascular brands including Cardace, Clexane, Targocid, Lasix, and Lasilactone.
Tags
StockBeginner GuideAngel InvestingSME IPOEconomy MarketAIFInvestmentsMore
Stay Connected, Stay Informed –
Join Our
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.
Pre Ipo
Upcoming IPO
Unicorn